Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04564703 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT04564703 · ClinicalTrials.gov record · last posted 2026-07-16

Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients

StatusActive, Not Recruiting
PhasePhase 2
Started2021-02-22
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This is a phase II study to evaluate the efficacy and safety of different doses of iberdomide continuous therapy as maintenancetreatment after transplant.

Amendment record 9 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 9 times since 2020-09-21; most recent amendment 2026-07-15. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2023-09-06
Status change Recruiting→Active, Not Recruitingv6
2021-08-18
Status change Not Yet Recruiting→Recruitingv3
Trial Details
NCT Number NCT04564703
Lead Sponsor Stichting European Myeloma Network
Collaborators: Healt Data Specialists - HeaDS (CRO), EMN Research Italy Impresa Sociale Srl
Conditions Multiple Myeloma
Enrollment 160 participants
Start Date 2021-02-22
Primary Completion 2023-07-27 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-16